Background: Many factors, including molecular ones, were demonstrated to be associated with long-termprognosis of hepatocellular carcinoma (HCC). Thus far, the expression and clinicopathologic and prognosticsignificance of the carboxyl terminus of Hsp70-interacting protein (CHIP) in B-type hepatitis virus (HBV)-related HCC remain unknown. Materials and Methods: CHIP expression was detected by immunohistochemicalstaining of surgical samples from 79 patients with HCC with HBsAg positivity. In addition, correlations withclinicopathologic parameters and patient survival were evaluated. Results: It was found that positive CHIPstaining was observed in tumor, but not non-tumor, tissues. High expression of CHIP was significantly related tolarger tumor size, with marginally significant associations noted for presence of portal vein invasion and higherserum a-fetoprotein level. In addition, univariate analysis showed that high CHIP expression was a powerfulpredictor for dismal overall and disease-free survival. However, independent prognostic implications of CHIPwere not proven in multivariate Cox regression test. Conclusions: CHIP is overexpressed in HBV-related HCCand is associated with unfavorable biological behavior as well as poor prognosis. However, its prognostic roleneeds to be further validated.
(2015). Clinicopathologic and Prognostic Significance of Carboxyl Terminus of Hsp70-interacting Protein in HBV-related Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention, 16(9), 3709-3713.
MLA
. "Clinicopathologic and Prognostic Significance of Carboxyl Terminus of Hsp70-interacting Protein in HBV-related Hepatocellular Carcinoma". Asian Pacific Journal of Cancer Prevention, 16, 9, 2015, 3709-3713.
HARVARD
(2015). 'Clinicopathologic and Prognostic Significance of Carboxyl Terminus of Hsp70-interacting Protein in HBV-related Hepatocellular Carcinoma', Asian Pacific Journal of Cancer Prevention, 16(9), pp. 3709-3713.
VANCOUVER
Clinicopathologic and Prognostic Significance of Carboxyl Terminus of Hsp70-interacting Protein in HBV-related Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention, 2015; 16(9): 3709-3713.